Pfizer - ENTERPRISE
Christine Kobryn, PhD. Director, Pfizer Global Regulatory Affairs
Dr. Kobryn is a Director within the Global Regulatory Affairs team supporting oncology and biosimilar products at Pfizer Inc. She is located at the Pfizer Connecticut Research Laboratories in Groton, CT where she is a global regulatory lead. Christine has been working in the area of biosimilars since 2015 and has engaged with regulatory agencies including FDA, EMA, PMDA and Health Canada regarding a range of biosimilar development topics. She is a highly experienced regulatory professional with over 25 years in industry. Her broad experience spans the entire drug development lifecycle for both new chemical entities (small molecules) as well as monoclonal antibodies and has included preparation of global regulatory dossiers for these medicines. Christine obtained her PhD in biochemistry at The George Washington University (US).
Wednesday, September 16, 2020
10:35 AM – 11:30 AM EDT